Zobrazeno 1 - 10
of 132
pro vyhledávání: '"A. C. Heng"'
Autor:
L. Abdullah, N.M. Apandi, N.M. Sunar, S.N.H. Arifin, M. Haron, R. Nagarajah, K. Cheong, C. Heng, C.F. Soon, M. Nabiałek
Publikováno v:
Archives of Metallurgy and Materials, Vol vol. 69, Iss No 3, Pp 981-986 (2024)
Palm Oil Mill Effluent Materials (POME) are significantly more contaminated than municipal sewage due to their high chemical and biological oxygen demand (BOD and COD). This study examines the properties of POME wastewater under typical physical sett
Externí odkaz:
https://doaj.org/article/5cd16ef9f4a240f080981ab6d3765c53
Autor:
Mehul Gupta, Igor Stukalin, Daniel E. Meyers, Daniel Y. C. Heng, Jose Monzon, Tina Cheng, Vishal Navani
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe association between objective imaging response and first line immune checkpoint inhibitor (ICI) therapy regimes in advanced melanoma remains uncharacterized in routine practice.MethodsWe conducted a multi-center retrospective cohort ana
Externí odkaz:
https://doaj.org/article/3a7a0cf228e44e9382aeb927341c82e3
Autor:
Daniel Y C Heng, Kosuke Takemura
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/2e9177ee907549c2a981e4f1ade9c431
Autor:
Taylor E. Woo, Igor Stukalin, Philip Q. Ding, Siddhartha Goutam, Michael Sander, Benjamin Ewanchuk, Winson Y. Cheung, Daniel Y. C. Heng, Tina Cheng
Publikováno v:
Current Oncology, Vol 30, Iss 10, Pp 8936-8947 (2023)
Background: The majority of melanoma is diagnosed in individuals between 55 and 84 years old. Current data varied in reporting differences in survival outcomes amongst different age groups. Methods: A retrospective, multi-center, provincial cohort da
Externí odkaz:
https://doaj.org/article/d3356bccbd954bebb8c1372aca614954
Autor:
Ambica Parmar, Sunita Ghosh, Arjun Sahgal, Aly‐Khan A. Lalani, Aaron R. Hansen, M. Neil Reaume, Lori Wood, Naveen S. Basappa, Daniel Y. C. Heng, Jeffrey Graham, Christian Kollmannsberger, Denis Soulières, Rodney H. Breau, Simon Tanguay, Anil Kapoor, Frédéric Pouliot, Georg A. Bjarnason
Publikováno v:
Cancer Reports, Vol 6, Iss 3, Pp n/a-n/a (2023)
Abstract Background Brain metastases (BM) in metastatic renal cell carcinoma (mRCC) have been reported to be present in up to 25% of patients diagnosed with mRCC. There is limited published literature evaluating the role of routine intra‐cranial im
Externí odkaz:
https://doaj.org/article/092dbeb3dad24a6c923e32e6476ded01
Autor:
Nicole E. Mealey, Dylan E. O’Sullivan, Cheryl E. Peters, Daniel Y. C. Heng, Darren R. Brenner
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-9 (2021)
Abstract Background Incidence of testicular cancer is highest among young adults and has been increasing dramatically for men born since 1945. This study aimed to elucidate the factors driving this trend by investigating differences in mutational sig
Externí odkaz:
https://doaj.org/article/b300a6f7c3ce458089ca8c690cc00b74
Autor:
Ellen Cusano, Chelsea Wong, Eddy Taguedong, Marcus Vaska, Tasnima Abedin, Nancy Nixon, Safiya Karim, Patricia Tang, Daniel Y. C. Heng, Doreen Ezeife
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4894-4928 (2021)
In the era of rapid development of new, expensive cancer therapies, value frameworks have been developed to quantify clinical benefit (CB). We assessed the evolution of CB since the 2015 introduction of The American Society of Clinical Oncology and T
Externí odkaz:
https://doaj.org/article/e8bdd00222fe45b39718365154b929ed
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Heidi A. I. Grosjean, Samantha Dolter, Daniel E. Meyers, Philip Q. Ding, Igor Stukalin, Siddhartha Goutam, Shiying Kong, Quincy Chu, Daniel Y. C. Heng, D. Gwyn Bebb, Don G. Morris, Winson Y. Cheung, Aliyah Pabani
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 4213-4222 (2021)
The emergence of immunotherapy revolutionized the treatment of non-small-cell-lung cancer (NSCLC), with multiple landmark clinical trials establishing the efficacy of these agents. However, many patients who receive immunotherapy in clinical practice
Externí odkaz:
https://doaj.org/article/ef1a3db40d2d4a92a300be45448be0e8
Autor:
Aly-Khan A. Lalani, Daniel Y. C. Heng, Naveen S. Basappa, Lori Wood, Nayyer Iqbal, Deanna McLeod, Denis Soulières, Christian Kollmannsberger
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Renal cell carcinoma (RCC) is a common malignancy with approximately 30% of cases diagnosed at the advanced or metastatic stage. While single-agent vascular endothelial growth factor-targeted therapy has been a mainstay of treatment, data
Externí odkaz:
https://doaj.org/article/b4984d0e2fe74a72a65714b7537757fe